NIPT Test in India: Cost, Accuracy & How to Book Online

The NIPT (Non-Invasive Prenatal Testing) is a safe prenatal blood test that screens for common chromosomal conditions, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), from the 10th week of pregnancy. In India, NIPT typically costs ₹12,500-₹17,500 with home sample collection and online reports available through MyDiagnostics.

What Is an NIPT Test?

Non-Invasive Prenatal Testing (NIPT) is a prenatal screening test that analyzes fetal cell-free DNA (cfDNA) in the mother's blood to assess the risk of certain chromosomal abnormalities, including Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13. It is performed from 10 weeks of pregnancy, is highly accurate for common chromosomal conditions, and poses no risk to the mother or baby because it only requires a blood sample.

What Does NIPT Stand For?

NIPT (Non-Invasive Prenatal Testing) is an advanced prenatal blood test that analyzes small fragments of fetal DNA (cell-free DNA) circulating in the mother's bloodstream. It helps estimate the risk of certain chromosomal conditions in the baby without harming the pregnancy.

How Non-Invasive Prenatal Testing Works

NIPT requires a simple blood sample from the pregnant woman, usually from 10 weeks of pregnancy onward. The test examines fetal cell-free DNA (cfDNA) to screen for chromosomal abnormalities such as Down syndrome (Trisomy 21), Trisomy 18, Trisomy 13, and, in some cases, sex chromosome conditions.

Is NIPT a Screening Test or a Diagnostic Test?

NIPT is a screening test, not a diagnostic test. While it offers high accuracy for common chromosomal abnormalities, a high-risk result should be confirmed with diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis before making medical decisions.

Is NIPT Safe During Pregnancy?

Yes. NIPT is considered safe for both the mother and the baby because it only requires a maternal blood sample. Unlike invasive diagnostic tests, it carries no risk of miscarriage, making it a preferred first-line prenatal screening option for many pregnancies.

What Does the NIPT Test Screen For?

NIPT screens for the most common chromosomal abnormalities by analyzing fetal cell-free DNA (cfDNA) in the mother's blood. It provides a risk assessment for specific genetic conditions but does not diagnose them. Positive results should be confirmed with diagnostic testing.

Trisomy 21 (Down Syndrome)

NIPT accurately screens for Down syndrome (Trisomy 21), a condition caused by an extra copy of chromosome 21. It is the most common chromosomal disorder detected through prenatal screening.

Trisomy 18 (Edwards Syndrome)

NIPT screens for Edwards syndrome (Trisomy 18), a rare chromosomal condition associated with severe developmental abnormalities and a high risk of pregnancy loss or infant mortality.

Trisomy 13 (Patau Syndrome)

NIPT detects the risk of Patau syndrome (Trisomy 13), a serious genetic condition that can affect the brain, heart, and other major organs.

Sex Chromosome Conditions

Some NIPT tests also screen for abnormalities involving the X and Y chromosomes, which may affect growth, development, fertility, or learning.

• Turner Syndrome: Caused by a missing or partially missing X chromosome (45, X) in females, Turner syndrome can affect growth, puberty, and heart health.

• Klinefelter Syndrome: Occurs when a male has an extra X chromosome (47, XXY). It may cause delayed puberty, infertility, and learning difficulties.

• Triple X Syndrome: Also called 47, XXX, this condition affects females with an extra X chromosome. Many have mild or no symptoms, although some may experience developmental delays.

• Jacobs Syndrome: Also known as 47, XYY syndrome, this condition affects males with an extra Y chromosome and may be associated with taller height and mild learning or behavioral differences.

What NIPT Does Not Detect

NIPT does not detect all genetic disorders, birth defects, or structural abnormalities. It cannot diagnose conditions such as neural tube defects, most single-gene disorders, or all chromosome abnormalities. A normal NIPT result does not guarantee a baby is free from all health conditions, making routine prenatal scans and follow-up testing essential.

NIPT Test Cost in India

The NIPT test cost in India typically ranges from ₹12,500-₹17,500 depending on the laboratory, test panel, and additional services. Premium tests that screen for a wider range of chromosomal conditions generally cost more than basic NIPT panels.

How Much Does the NIPT Test Cost in India?

The average NIPT test price in India starts at around ₹12,500 for standard screening and can go up to ₹17,500 or more for expanded genetic panels. Prices vary across cities and diagnostic providers.

MyDiagnostics NIPT Test Price

MyDiagnostics offers the NIPT test at competitive pricing with NABL-accredited laboratory processing, home sample collection, and expert support. Contact MyDiagnostics for the latest offers and city-specific pricing.

What Is Included in the Test Price?

The NIPT test price may include:

• Maternal blood sample collection

• Analysis of fetal cell-free DNA (cfDNA)

• Screening report for eligible chromosomal conditions

• Home sample collection (where available)

• Doctor or genetic counselling support (with selected packages)

Factors That Affect NIPT Cost

• Test panel: Basic panels cost less than expanded panels that screen for additional chromosomal conditions.

• Single vs Twin Pregnancy: NIPT for twin pregnancies may be priced differently due to more complex analysis.

• Home Collection: At-home blood sample collection may be included or charged separately, depending on the provider.

• Turnaround Time: Faster reporting options may increase the overall test cost.

• Genetic Counselling: Packages that include pre-test or post-test genetic counselling are generally priced higher.

Is NIPT Covered by Insurance?

In most cases, NIPT is not routinely covered by health insurance in India because it is considered an elective prenatal screening test. However, some insurers or corporate health plans may offer partial coverage, so it is advisable to check your policy before booking the test.

When Should You Take the NIPT Test?

NIPT can be performed from 10 weeks of pregnancy onward. Early testing allows timely risk assessment for common chromosomal abnormalities and helps guide any recommended follow-up testing.

Best Time to Take NIPT (10–17 Weeks)

NIPT can be performed from 10 completed weeks of pregnancy onward. Although it is most commonly performed during the first and early second trimester, it may also be performed later in pregnancy if clinically indicated.

Who Should Consider NIPT?

NIPT is recommended for all pregnant women, but it may be especially beneficial for those at a higher risk of chromosomal abnormalities.

• Women over 35: Pregnant women aged 35 years or older have a higher risk of certain chromosomal conditions, making NIPT a valuable screening option.

• IVF Pregnancy: NIPT is suitable for IVF pregnancies, including those conceived using donor eggs, as advised by a healthcare provider.

• Twin Pregnancy: Many NIPT tests are validated for twin pregnancies, providing reliable screening for common chromosomal abnormalities.

• Abnormal Ultrasound: NIPT may be recommended if an ultrasound detects findings that increase the risk of a chromosomal condition.

• Previous Chromosomal Disorder: Women with a previous pregnancy affected by a chromosomal abnormality may benefit from early prenatal screening with NIPT.

• Family History: A family history of genetic or chromosomal disorders may increase the need for prenatal genetic screening, including NIPT.

How the NIPT Blood Test Works

The NIPT blood test is a simple prenatal screening test that analyzes cell-free fetal DNA (cfDNA) in the mother's blood to assess the risk of common chromosomal abnormalities. The procedure is quick, safe, and non-invasive.

Blood Sample Collection

A healthcare professional collects a small blood sample from the mother's arm, usually from 10 weeks of pregnancy onward. No procedure is performed on the baby.

Cell-Free Fetal DNA Analysis (cfDNA)

The laboratory extracts and analyzes cell-free fetal DNA (cfDNA) present in the mother's bloodstream to screen for specific chromosomal abnormalities.

Next-Generation Sequencing (NGS)

Most NIPT tests use Next-Generation Sequencing (NGS) technology to accurately analyze fetal DNA fragments and estimate the risk of genetic conditions.

Documents Required

Patients are typically asked to provide a doctor's prescription, ultrasound report, pregnancy details, and a signed consent form before the test.

Does NIPT Require Fasting?

No. NIPT does not require fasting. You can eat and drink normally before providing your blood sample unless your doctor advises otherwise.

How Long Does the Test Take?

The NIPT blood sample collection takes only 5–10 minutes. After the sample is processed in the laboratory, results are usually available within 7–10 working days, depending on the laboratory and the test panel selected.

NIPT vs Other Prenatal Screening Tests

NIPT is one of the most accurate non-invasive prenatal screening tests available. Compared with traditional screening tests, it offers higher detection rates for common chromosomal abnormalities while posing no risk to the mother or baby. However, unlike amniocentesis and CVS, NIPT is a screening test, not a diagnostic test.

NIPT vs Dual Marker Test

According to the American College of Obstetricians and Gynaecologists (ACOG), the dual marker test is a first trimester screening test that measures two maternal blood markers. It is usually combined with the Nuchal Translucency ultrasound between 11 and 13 weeks plus 6 days of pregnancy.

The test estimates the risk of chromosomal conditions but has a lower detection rate than NIPT. NIPT analyzes cell free fetal DNA present in the mother's blood and offers significantly higher sensitivity and specificity for detecting trisomy 21, trisomy 18 and trisomy 13. Women with high-risk dual marker results are often advised to undergo NIPT or a diagnostic procedure for confirmation.

NIPT vs Quad Marker Test

The Quad Marker Test is generally performed between 15 and 22 weeks of pregnancy. It measures four biochemical markers in maternal blood to estimate the risk of Down syndrome, Edwards syndrome and neural tube defects.

Compared with the Quad Marker Test, NIPT can be performed earlier and provides much higher screening accuracy for common chromosomal abnormalities. However, the Quad Marker Test remains useful in pregnancies where first trimester screening was missed.

NIPT vs Combined First Trimester Screening

Combined First Trimester Screening includes the Dual Marker blood test along with a Nuchal Translucency ultrasound scan. It provides a calculated risk score for chromosomal abnormalities rather than directly analyzing fetal DNA.

NIPT directly evaluates placental DNA fragments circulating in maternal blood. This allows NIPT to achieve a detection rate of more than 99 per cent for Down syndrome with a much lower false positive rate than combined screening.

NIPT vs Amniocentesis

Amniocentesis is a diagnostic test performed after approximately 15 weeks of pregnancy. Unlike NIPT, it can confirm chromosomal abnormalities but carries a small procedure-related risk of miscarriage.

Unlike NIPT, amniocentesis provides a definitive diagnosis rather than a risk estimate. However, because it is invasive, it carries a small risk of pregnancy loss and is usually recommended only when screening results suggest a higher risk.

NIPT vs Chorionic Villus Sampling (CVS)

Chorionic Villus Sampling is another diagnostic procedure usually performed between 10 and 13 weeks of pregnancy. A small placental tissue sample is collected through the cervix or abdomen for genetic testing.

CVS provides a confirmed diagnosis of chromosomal disorders but is invasive and carries a small miscarriage risk. NIPT offers a much safer screening option, although positive NIPT results should still be confirmed using CVS or amniocentesis before making pregnancy management decisions.

Comparison Table

Understanding Your NIPT Results

NIPT results help estimate whether your baby has a high or low chance of certain chromosomal abnormalities. Because NIPT is a screening test, every report should be interpreted together with your pregnancy history, ultrasound findings and your doctor's clinical assessment.

What Does a Low-Risk Result Mean?

A low-risk result means the chance of the screened chromosomal conditions is very low. Most pregnancies with a low-risk NIPT result are healthy, but the test cannot completely rule out every genetic condition or birth defect.

What Does a High-Risk Result Mean?

According to the Society for Maternal Fetal Medicine (SMFM), a high-risk result means that the screening test has found a higher chance that your baby may have a particular genetic or chromosomal condition. It is important to understand that this does not confirm that the baby has the condition. Screening tests estimate the level of risk but cannot provide a definitive diagnosis.

What Happens After a Positive NIPT?

If your NIPT result is positive, your doctor will usually recommend genetic counselling and a confirmatory diagnostic test such as CVS or amniocentesis. Ultrasound evaluation may also be advised before making any pregnancy-related decisions.

Can NIPT Give False Positive or False Negative Results?

Yes, although NIPT is highly accurate, it is not perfect. Factors such as confined placental mosaicism, maternal chromosomal variations, vanishing twin pregnancy and very low fetal fraction may occasionally lead to false positive or false negative results.

When Is Repeat Testing Recommended?

Repeat NIPT may be recommended if there is insufficient fetal DNA in the blood sample or if the laboratory reports an inconclusive result. Your healthcare provider may also recommend repeat testing or direct diagnostic testing depending on the clinical situation.

Can NIPT Determine Your Baby's Gender?

NIPT analyzes fetal DNA, including the sex chromosomes. In many countries, the test can identify fetal sex early in pregnancy, but local laws determine whether this information can legally be disclosed.

Does NIPT Analyze Sex Chromosomes?

Yes. Most expanded NIPT panels evaluate the X and Y chromosomes and may identify sex chromosome abnormalities such as Turner syndrome and Klinefelter syndrome. The availability of this analysis depends on the selected test panel.

What Does India's PC-PNDT Act Say?

The Pre-Conception and Pre-Natal Diagnostic Techniques Act strictly prohibits prenatal sex determination and disclosure of fetal sex in India except under legally permitted medical circumstances. The law aims to prevent sex selective practices and protect gender equality.

Why MyDiagnostics Does Not Reveal Fetal Sex

MyDiagnostics fully complies with the PC PNDT Act and does not disclose fetal gender in any NIPT report performed in India. This ensures complete legal compliance while maintaining ethical prenatal care standards.

Why Choose MyDiagnostics for NIPT Testing?

Choosing a reliable laboratory is essential because sample quality, laboratory standards and expert interpretation all influence the overall testing experience. MyDiagnostics partners with accredited laboratories and provides end-to-end support throughout your pregnancy screening journey.

NABL Accredited Laboratory

Your sample is processed in NABL-accredited laboratories that follow strict quality control protocols. This helps ensure reliable testing and internationally accepted laboratory standards.

Home Blood Sample Collection

A trained phlebotomist collects your blood sample safely from your home at your preferred time. Home collection provides greater comfort and convenience during pregnancy.

Doctor-Reviewed Reports

NIPT reports are reviewed by experienced laboratory specialists and healthcare professionals before release. Your doctor can explain the findings and discuss any further testing if needed.

Transparent Pricing

MyDiagnostics offers clear pricing with no hidden charges. Patients know the complete testing cost before booking their appointment.

Fast Turnaround Time

Most NIPT reports are available within approximately 7 to 10 working days, depending on the selected laboratory and testing panel. Timely reporting helps reduce anxiety during pregnancy.

Online Reports and Support

Patients can securely download reports online from anywhere. Dedicated customer support assists with booking report access and coordination with healthcare providers whenever needed.

How to Book an NIPT Test Online

Booking an NIPT test online is simple and can be completed within a few minutes. MyDiagnostics offers a smooth booking process with home sample collection and digital report delivery.

Choose Your Test Panel

Select the NIPT package recommended by your doctor based on your pregnancy history, age and clinical requirements. Different panels may include screening for common trisomies, sex chromosome abnormalities, and selected microdeletions.

Schedule Home Sample Collection

Choose your preferred date and time for blood sample collection. A trained healthcare professional visits your home and collects the required blood sample using standard safety protocols.

Laboratory Processing

The collected sample is transported under controlled conditions to an accredited laboratory. Advanced DNA sequencing and bioinformatics analysis are performed to evaluate fetal chromosomal risk.

Download Your Report Online

Once testing is complete, you receive a secure notification to access your report online. You can share the report with your obstetrician or genetic counsellor for further consultation and pregnancy planning.